Swiss National Bank
PRNB

Swiss National Bank’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

Swiss National Bank’s Portfolio PRNB Stock Details PRNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-54,800
Closed -$3.28M – 2433
2020
Q2 		$3.28M Buy
54,800
+10,300
+23% +$636K ﹤0.01% 1406
2020
Q1 		$2.64M Buy
44,500
+2,300
+5% +$134K ﹤0.01% 1281
2019
Q4 		$2.31M Buy
42,200
+26,600
+171% +$993K ﹤0.01% 1651
2019
Q3 		$441K Hold
15,600
– – ﹤0.01% 2396
2019
Q2 		$518K Buy
+15,600
New +$487K ﹤0.01% 2406

Other funds holding PRNB

Ohio Public Employees Retirement System (OPERS)
Ohio Public Employees Retirement System (OPERS) Columbus, Ohio $34B AUM 40.73% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Public Employees Retirement Association of Colorado
Public Employees Retirement Association of Colorado Denver, Colorado $28.9B AUM 44.1% 1-Year Est. Return
AB
Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ADL
Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return

Swiss National Bank's PRNB Position: Q3 2020 in Review

Swiss National Bank sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q3 2020, closing a stake of 54,800 shares — an estimated $3.28M sold.

Swiss National Bank first reported a position in PRNB in Q2 2019 and held it in 5 quarters. The position peaked at $3.28M in Q2 2020. 9 funds tracked by Wall St. Rank hold PRNB as of Q3 2020.

  • Swiss National Bank reported no remaining Principia Biopharma Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Swiss National Bank sold 54,800 Principia Biopharma Inc. Common Stock shares in Q3 2020, an estimated $3.28M.
  • Swiss National Bank first reported a position in Principia Biopharma Inc. Common Stock in Q2 2019 and held it in 5 quarters.
  • Swiss National Bank's Principia Biopharma Inc. Common Stock position peaked at $3.28M in Q2 2020.
  • 9 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q3 2020.

Based on Swiss National Bank's 13F filing for Q3 2020, filed 9 Nov 2020.